ABL gets $102M NIH contract for vaccines and biologics
03:36 EDT 2 Aug 2012 | SmartBrief
Advanced BioScience Laboratories landed a 10-year contract worth up to $102 million from the National Institute of Allergy an -More-
Original Article: ABL gets $102M NIH contract for vaccines and biologics
More From BioPortfolio on "ABL gets $102M NIH contract for vaccines and biologics"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
